BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6196106)

  • 1. Antitumour activity of endotoxin, concanavalin A and poly I: C and their ability to elicit tumour necrosis factor, cytostatic factors, and interferon in vivo.
    Bloksma N; Kuper CF; Hofhuis FM; Benaissa-Trouw B; Willers JM
    Cancer Immunol Immunother; 1983; 16(1):35-9. PubMed ID: 6196106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotoxin-induced release of tumour necrosis factor and interferon in vivo is inhibited by prior adrenoceptor blockade.
    Bloksma N; Hofhuis F; Benaissa-Trouw B; Willers J
    Cancer Immunol Immunother; 1982; 14(1):41-5. PubMed ID: 6186366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of vasoactive amines in the antitumor activity of endotoxin.
    Bloksma N; Kuper CF; Hofhuis FM; Willers JM
    Immunopharmacology; 1984 Jun; 7(3-4):201-9. PubMed ID: 6469605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of histamine in the antitumour activity of endotoxin.
    Bloksma N; van de Wiel P; Hofhuis F; Kuper F; Willers J
    Cancer Immunol Immunother; 1984; 17(1):33-7. PubMed ID: 6563942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tumour necrosis factor in the tumour-necrotizing activity of agents with diverging toxicity.
    van de Wiel PA; van der Pijl A; Bloksma N
    Cancer Immunol Immunother; 1991; 33(2):115-20. PubMed ID: 2036659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of various coryneforms on mononuclear phagocyte system function and on production of tumour necrosis factor in mice.
    Bloksma N; de Leeuw R; Hofhuis FM; Westerdaal NA; Benaissa-Trouw B; Willers JM
    Ann Immunol (Paris); 1983; 134C(1):159-64. PubMed ID: 6190428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of mononuclear phagocyte function in endotoxin-induced tumor necrosis.
    Bloksma N; Hofhuis FM; Willers JM
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):397-403. PubMed ID: 6368247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic action of human recombinant tumor necrosis factor with endotoxins or nontoxic poly A:U against solid Meth A tumors in mice.
    Bloksma N; Hofhuis FM
    Cancer Immunol Immunother; 1987; 24(2):165-71. PubMed ID: 3829051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Definition of tumor-necrosis factor and its production mechanism].
    Urushizaki I; Niitsu Y; Watanabe N
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1356-68. PubMed ID: 6378100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarities of the anti-tumour actions of endotoxin, lipid A and double-stranded RNA.
    Parr I; Wheeler E; Alexander P
    Br J Cancer; 1973 May; 27(5):370-89. PubMed ID: 4713170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction of tumor necrosis factor (TNF) in tumor-bearing mice].
    Tamura K; Ishida N
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1369-78. PubMed ID: 6378101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-necrosis factor from the rabbit. III. Relationship to interferons.
    Matthews N
    Br J Cancer; 1979 Oct; 40(4):534-9. PubMed ID: 387059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lipid A of endotoxin in the production of tumour necrosis factor.
    Ha DK; Leung SW; Fung KP; Choy YM; Lee CY
    Mol Immunol; 1985 Mar; 22(3):291-4. PubMed ID: 4000132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adrenoceptor blockade on hemorrhagic necrosis of meth A sarcomata induced by endotoxin or tumor necrosis serum.
    Bloksma N; Hofhuis FM; Willers JM
    Immunopharmacology; 1982 Apr; 4(2):163-71. PubMed ID: 7085258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of interferons produced by peripheral blood mononuclear cells from healthy subjects in response to Corynebacterium parvum or poly I: poly C.
    Hertzog PJ; Cheetham BF; Sexton JL; Linnane AW
    Biochem Int; 1989 Dec; 19(6):1427-36. PubMed ID: 2483976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muramyl dipeptide is a powerful potentiator of the antitumor action of various tumor-necrotizing agents.
    Bloksma N; Hofhuis FM; Willers JM
    Cancer Immunol Immunother; 1984; 17(3):154-9. PubMed ID: 6566601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An endotoxin-induced serum factor that causes necrosis of tumors.
    Carswell EA; Old LJ; Kassel RL; Green S; Fiore N; Williamson B
    Proc Natl Acad Sci U S A; 1975 Sep; 72(9):3666-70. PubMed ID: 1103152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taurolidine inhibits tumour necrosis factor (TNF) toxicity--new evidence of TNF and endotoxin synergy.
    Monson JR; Ramsey PS; Donohue JH
    Eur J Surg Oncol; 1993 Jun; 19(3):226-31. PubMed ID: 8314379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antitumor function of tumor necrosis factor (TNF) II. Analysis of the role of endogenous TNF in endotoxin-induced hemorrhagic necrosis and regression of an established sarcoma.
    North RJ; Havell EA
    J Exp Med; 1988 Mar; 167(3):1086-99. PubMed ID: 3258350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of tumor necrosis factor in unprimed mice: mechanism of endotoxin-mediated tumor necrosis.
    Flick DA; Gifford GE
    Immunobiology; 1986 Jul; 171(4-5):320-8. PubMed ID: 3527951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.